Pinnacle Associates LTD Bio N Tech Se Transaction History

Pinnacle Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$126.25 - $231.85 $111,731 - $205,187	-885 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$216.64 - $362.52 $1.61 Million - $2.69 Million	-7,427 Reduced 89.35%	885 $228,000
Q3 2021 Oct 19, 2021	BUY	$205.93 - $447.23 $518,325 - $1.13 Million	2,517 Added 43.43%	8,312 $2.27 Million
Q4 2020 Jan 26, 2021	BUY	$72.71 - $129.54 $421,354 - $750,684	5,795 New	5,795 $472,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Associates LTD with notifications on news.